These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26789131)

  • 1. Activity and distribution of plasma platelet-activating factor acetylhydrolase in women with gestational diabetes mellitus and their neonates.
    Gao Q; He GL; Zhang L; Bai H; Liu XH; Fan P
    Diabetes Metab Res Rev; 2016 Sep; 32(6):634-42. PubMed ID: 26789131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal and fetal plasma platelet-activating factor acetylhydrolase activity and distribution in pre-eclampsia.
    Fan P; Liu XH; He GL; Zhang S; Zhang JX; Bai H
    Pediatr Res; 2012 Oct; 72(4):426-31. PubMed ID: 22797139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome.
    Zhang R; Song Q; Liu H; Bai H; Zhang Y; Liu Q; Guan L; Fan P
    Lipids Health Dis; 2017 Mar; 16(1):57. PubMed ID: 28320416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the G994T and R92H genotypes of platelet-activating factor acetylhydrolase with risk of preeclampsia in Chinese women.
    Zhou M; Chen M; Bai H; He GL; Liu QQ; Guan LB; Liu XH; Fan P
    Pregnancy Hypertens; 2020 Apr; 20():19-26. PubMed ID: 32145524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
    Fan P; Liu H; Wang Y; Zhang F; Bai H
    Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats.
    Wójcicka G; Zaręba M; Warpas A; Jamroz-Wiśniewska A; Rusek M; Czechowska G; Bełtowski J
    Eur J Pharmacol; 2019 May; 850():180-189. PubMed ID: 30768981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
    Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
    Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus.
    Derbent A; Kargili A; Koca C; Gümüş Iİ; Sevgili S; Simavli S; Karakurt F; Turhan NÖ
    Gynecol Endocrinol; 2011 Feb; 27(2):128-33. PubMed ID: 20504094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome.
    Fan P; Liu HW; Wang XS; Zhang F; Song Q; Li Q; Wu HM; Bai H
    Hum Reprod; 2010 May; 25(5):1288-94. PubMed ID: 20185515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid.
    Kujiraoka T; Hattori H; Ito M; Nanjee MN; Ishihara M; Nagano M; Iwasaki T; Cooke CJ; Olszewski WL; Stepanova IP; Egashira T; Miller NE
    Atherosclerosis; 2004 Sep; 176(1):57-62. PubMed ID: 15306175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
    Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration.
    Zhang B; Fan P; Shimoji E; Itabe H; Miura S; Uehara Y; Matsunaga A; Saku K
    Atherosclerosis; 2006 Jun; 186(2):291-301. PubMed ID: 16154574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.
    Eisaf M; Tselepis AD
    Biochem Pharmacol; 2003 Dec; 66(11):2069-73. PubMed ID: 14609731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity.
    Tselepis AD; Elisaf M; Besis S; Karabina SA; Chapman MJ; Siamopoulou A
    Arthritis Rheum; 1999 Feb; 42(2):373-83. PubMed ID: 10025933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
    Kujiraoka T; Iwasaki T; Ishihara M; Ito M; Nagano M; Kawaguchi A; Takahashi S; Ishi J; Tsuji M; Egashira T; Stepanova IP; Miller NE; Hattori H
    J Lipid Res; 2003 Oct; 44(10):2006-14. PubMed ID: 12867534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
    Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
    Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation.
    Okamura K; Miura S; Zhang B; Uehara Y; Matsuo K; Kumagai K; Saku K
    Circ J; 2007 Feb; 71(2):214-9. PubMed ID: 17251670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of maternal plasma platelet activating factor acetylhydrolase activity and mRNA expression in pre-eclampsia: a case control study.
    Gupta P; Agarwal R; Bhaskaran S; Garg S; Mehndiratta M; Radhakrishnan G; Singh A; Agarwal R; Narang D
    J Obstet Gynaecol; 2021 Jul; 41(5):726-732. PubMed ID: 33073639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.